Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Banca Generali raised its 2026 net interest income guidance, citing expected interest rate increases during the year. The private bank posted stronger first-quarter earnings and healthy net inflows, and has submitted a binding bid to buy a majority stake in Investlinx, an Irish ETF platform managing about 240 million euros.
Egypt's annual consumer inflation fell to 14.9% in April from 15.2% in March, while monthly inflation slowed to 1.1% from 3.2%. The weaker monthly print reduces near-term odds of a rate hike at the central bank's May 21 policy meeting, even as the economy faces imported energy costs, a softer pound and capital outflows tied to the Iran war.
Amprius (AMPX) is trading near its 52-week high after a sustained rally driven by production progress, NDAA-related defense access, and strong trading flow. The company is priced like a growth winner — market cap ~$2.93B, P/S ~40 — so the trade is a bet that near-term execution (ramp, orders, yields) keeps accelerating. I outline a mid-term swing l…
Hut 8 announced a 15-year, $9.8 billion triple-net lease for 352 MW of IT capacity at its Beacon Point AI campus in Nueces County, Texas, sending the company’s shares higher by 37%. The deal raises Hut 8’s total contracted AI data center capacity to 597 MW and carries projected cumulative NOI of $9.8 billion over the base lease term, with an expect…
A study prepared for China’s Chamber of Commerce to the EU estimates that proposed EU cybersecurity rules phasing out equipment from so-called "high-risk" suppliers across 18 critical sectors would cost the bloc 367.8 billion euros ($432.83 billion) between 2026 and 2030. Germany would shoulder the largest share, with projected losses of 170.8 bill…
Egypt's urban consumer price inflation dropped to 14.9% year on year in April from 15.2% in March, according to official statistics from CAPMAS. On a monthly basis, overall prices rose 1.1% in April while food and beverage costs fell 0.7% month on month but remained 6.7% higher than a year earlier. Analysts had expected inflation to rise, citing re…
Luckin is a scale-first, tech-driven coffee chain with rapid unit growth and recovering customer metrics. Near-term headline noise and a controlling-shareholder deal create debate, but revenue growth and a sub-$10B market cap argue for a long-biased trade with a disciplined stop.
Alkermes ($ALKS) is a cash-flowing CNS company that just picked up a sleep medicine asset (Lumryz) via the Avadel deal. The stock is trading near its 52-week high but still offers asymmetric upside to $42.50 if Lumryz momentum and the core CNS portfolio line up. This trade plan targets a mid-term swing (45 trading days) with a disciplined stop at $…
J.P. Morgan upgraded Aker Solutions to a neutral rating from underweight and set a December 2027 price target of Nkr45, pointing to a notable increase in Asia-Pacific tendering, stronger backlog visibility and an improved medium-term earnings trajectory. The bank preserved a cautious note about elevated forward multiples and potential execution and…
Medicus Pharma Ltd. announced expanded pre-specified data from its Phase 2 SKNJCT-003 study showing a positive, dose-dependent response for its Doxorubicin Microneedle Array (D-MNA) treatment of nodular basal cell carcinoma, strengthening the drug's clinical profile and regulatory positioning ahead of FDA discussions. The 200µg dose cohort showed t…
BridgeBio Pharma announced that the Brazilian regulatory agency ANVISA has approved acoramidis, marketed as Beyonttra, for treatment of transthyretin amyloidosis cardiomyopathy (ATTR-CM). This approval follows positive Phase 3 trial results demonstrating significant reductions in cardiovascular events and hospitalizations, marking the first near-co…
Kura Oncology, a biopharmaceutical company focused on precision cancer medicines, announced its participation in the Bank of America Securities 2026 Healthcare Conference, featuring a fireside chat with company management where they will discuss their pipeline and recent FDA-approved drug KOMZIFTI™ for acute myeloid leukemia.
StepStone Group Inc., a global private markets investment firm, announced it will release its financial results for the fourth quarter and fiscal year ended March 31, 2026, on May 20, 2026, followed by a webcast and conference call to discuss the results.
Dragonfly Energy Holdings Corp. has been awarded a second round of funding from the Nevada Tech Hub, amounting to $527,000, to expand its in-house cylindrical lithium battery cell prototyping and advanced testing capabilities. This investment aims to accelerate research and development, enhance validation processes, and strengthen integration betwe…
Cronos Group Inc., a global cannabis company, announced the expanded availability of its Spinach STIX®, a cylindrical-style pre-roll, across multiple Canadian provinces. This expansion targets the rising consumer demand for innovative and portable cannabis pre-roll formats in the Canadian market, which accounts for over a third of national retail c…
BriaCell Therapeutics has received FDA clearance to initiate clinical trials for Bria-BRES+, its next-generation personalized immunotherapy targeting metastatic breast cancer. Building on promising results from the earlier Bria-OTS program, the new therapy aims to enhance immune activation and offer improved efficacy. The company plans to start the…
Bioventus Inc. reported solid financial results for Q1 2026, with revenue increasing 7% to $132.1 million driven by growth across its Pain Treatments, Surgical Solutions, and Restorative Therapies segments. GAAP earnings improved to $0.04 per diluted share from a prior year loss, and non-GAAP earnings nearly doubled to $0.15 per diluted share. The …
Since its Nasdaq listing in early 2026, VenHub Global, Inc. has accelerated growth by expanding its Las Vegas production capacity, advancing autonomous retail technology, securing multiple new Smart Store deployment agreements, and strengthening its payments platform. The company aims to transform high-traffic venues across key sectors by offering …
Applied Materials, Inc. announced that its senior management team will participate in several upcoming investor conferences, including J.P. Morgan, Bernstein, and BofA Securities events. The company will webcast their sessions, providing updates on their materials engineering solutions critical to semiconductor and advanced display industries. The …
Medline Inc. announced first quarter 2026 results showing strong net sales growth of 10.7% to $7.4 billion driven by new customer signings and organic growth, while net income declined 25.8% to $239 million due to increased costs and expenses including tariffs and IPO-related employee bonuses. The company raised its full year 2026 organic sales gro…
Crescent Biopharma, a clinical-stage biotechnology company specializing in oncology therapies, will present at several investor conferences throughout May 2026, including BofA Securities Healthcare Conference, Stifel Virtual Targeted Oncology Forum, and TD Cowen Oncology Innovation Summit. The events feature virtual and in-person fireside chats foc…
Altimmune, a late clinical-stage biopharmaceutical company focused on therapies for serious liver diseases, will report its first quarter 2026 financial results on May 13, 2026. Management will host a conference call providing financial details and a business update the same day.
Holley Performance Brands reported its first quarter 2026 financial results, highlighting net income growth to $7.3 million and adjusted EBITDA margin expansion to 18.5%. Despite a slight decline in net sales due to portfolio optimization efforts, the company executed cost-saving initiatives, improved cash flow, and completed the acquisition of HRX…
ASP Isotopes Inc., a US-listed company, announces that its wholly-owned subsidiary Quantum Leap Energy (QLE) has appointed Dr. Peter S. Fiske to its Strategic Advisory Board. Dr. Fiske brings extensive experience in technology commercialization, government relations, and strategic partnerships, which is expected to bolster QLE's position in advanci…
Cameco (CCJ) is the pure-play uranium supplier best positioned to benefit from an accelerating global buildout of nuclear capacity. With a market cap near $49.9B, a large Western-aligned production base, a near-term string of commercial contracts and partnerships including a meaningful stake in Westinghouse, the stock offers a tradeable asymmetric …
